Merck Serono Co., Ltd., China
11
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
27.3%
3 terminated/withdrawn out of 11 trials
70.0%
-16.5% vs industry average
64%
7 trials in Phase 3/4
100%
7 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Pilot Study on Evaluating the Geroprotective Effect of Metformin
Role: collaborator
Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants
Role: collaborator
Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants
Role: collaborator
Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease
Role: collaborator
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
Role: collaborator
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment
Role: collaborator
A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
Role: collaborator
Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina
Role: collaborator
Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients
Role: collaborator
Colposeptine for the Treatment of Bacterial Vaginosis
Role: collaborator
Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®
Role: collaborator
All 11 trials loaded